Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythromycin and Diltiazem Interaction on CYP3A Activity
NCT00318201Phase 4Completed
- Sponsor
- Indiana University School of Medicine
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of erythromycin, diltiazem, sponsored by Indiana University School of Medicine. Started Apr 2006; status: completed.
02
Drugs
erythromycindiltiazem
Beyond the preview
Go deeper on NCT00318201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00318201.